Presented By: Dr. Patrick Murray, Ph.D. Dr. Jordan Cardinal, PharmD, BCPS Speaker Biography: Dr. Patrick R. Murray received his Ph.D. degree in Microbiology at UCLA, postgraduate training in Clinical Microbiology at the Mayo Clinic in Rochester MN, and was director of the Clinical Microbiology Laboratories at Barnes-Jewish Hospital and Professor of Medicine and Pathology at Washington University from 1976-1999. In 1999, he joined the faculty of the University of Maryland School of Medicine and in 2001, he accepted the position of Senior Scientist and Chief of Microbiology at the National Institutes of Health (NIH). In July 2011, he retired from the NIH and accepted a position at BD Diagnostics as Vice President, Worldwide Scientific Affairs where he served until his retirement in 2021. He is a fellow of the American Academy of Microbiology and the Infectious Disease Society of America, member of the CLSI Consensus Committee for Antimicrobial Susceptibility Test Standards, former Chairman of the American Board of Medical Microbiology, former Editor-in-Chief of the ASM Manual of Clinical Microbiology from 1990 to 2010, former Editor of the Journal of Clinical Microbiology, and currently serves on numerous editorial boards. He has authored more than 275 research articles and 20 books. He is the recipient of numerous awards including the ASM Award for Research in Clinical Microbiology (1993), ASM Award for Leadership in Clinical Microbiology (2002), ASM Founders Distinguished Service Award (2010), and ABMM/ABMLI Professional Recognition Award (2011), as well as the Pasteur Lifetime Achievement Award (2007), NIH Clinical Center Director's Awards for Patient Care (2006) and Research (2010), and NIH Director's Award for Research (2007). Webinar: Challenges in Sepsis: Diagnostics and Patient Management Webinar Abstract: An estimated 49 million cases of sepsis occur globally each year with approximately 11 million deaths.1 Diagnostic tests, including cultures of the urinary tract, respiratory tract, and blood, are critical for guiding appropriate antibiotic therapy. This is particularly true for infections acquired in the hospital because many are caused by antimicrobial resistant bacteria. The success of blood cultures is dependent on collection of uncontaminated specimens, culture of a large volume of blood, and inoculation of multiple media types to maximize the recovery of most bloodstream pathogens. This lecture will review specific guidelines for specimen collection, selection of blood culture media, and the relationship between the volume of blood cultured and percent positive blood cultures, including the impact of prior exposure to antibiotics. LabRoots on Social: Facebook: https://www.facebook.com/LabRootsInc Twitter: https://twitter.com/LabRoots LinkedIn: https://www.linkedin.com/company/labroots Instagram: https://www.instagram.com/labrootsinc Pinterest: https://www.pinterest.com/labroots/ SnapChat: labroots_inc

https://www.luminexcorp.com/bloodstream-infection-tests/

Get Sample PDF here @ https://www.theinsightpartners.com/sample/TIPHE100001391/?utm_source=Youtube&utm_medium=10408 According to our latest study on "Sepsis Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Technology, Method, Test Type, Pathogen, and End User," the market is expected to grow from US$ 661.83 million in 2021 to US$ 1,226.52 million by 2028; it is estimated to grow at a CAGR of 9.2% from 2021 to 2028. The report highlights the key factors driving the market and prominent players with their developments. The sepsis diagnostics market growth is attributed to the high incidence of sepsis due to increasing nosocomial infections and rise in demand for rapid diagnostic tests leading to increasing product launches. However, the lack of skilled professionals hampers the market growth. Product launches and approvals are among the most commonly adopted strategies by companies to expand their global footprints and product portfolios. Market players also focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world. Abbott; F. HOFFMANN-LA ROCHE LTD.; Immunexpress Inc.; BD; Danaher; Luminex Corporation; THERMO FISHER SCIENTIFIC INC.; bioMerieux SA; T2 Biosystems, Inc.; and Axis-Shield Diagnostics Ltd are among the leading companies operating in the sepsis diagnostics market growth.

This session with guest speakers from Thermo Fisher Scientific covers the diverse range of careers available with the company from science, sales, IT and finance. Hear from a panel of professionals working in the sector sharing information about their role, career progression and what they expect from students looking to apply for Thermo Fisher Scientific graduate roles.

Successful outsourcing strategies for the development and manufacturing of biologics -Patheon, by Thermo Fisher Scientific More and more companies are looking for a CDMO partner to advance their molecule into Phase I clinical trials as quickly as possible. Patheon’s Quick to Clinic program can deliver released drug substance (IgG1 or IgG4) starting from DNA in just 14 months. This is 6 months faster than most other standard timelines and includes a cell line documentation package, non-GMP drug substance for toxicology studies, released GMP drug substance for First-in-Human studies, viral clearance data and at least one month of stability data. Although speed is important, a strong quality track record, flexibility, and technical expertise should also be key attributes of your selected CDMO. Molecule formats such as Fc-fusions, bispecific antibodies, and non-antibody recombinant proteins are becoming more popular but can be challenging to develop. Patheon has expertise with these molecule types and can apply many of the Quick to Clinic strategies to identify suitable manufacturing processes ASAP.

This is the official opening of the BioProduction Single-Use Technology Lebanon, TN site. The 400,000-square-foot facility enables us to help meet rapidly growing demand of bioprocessing materials to produce vaccines and breakthrough therapies for cancer and other diseases.

Reliable Analysis of Ethylene Oxide and 2-chloroethanol in Food Samples using Gas Chromatography Mass Spectrometry

Applied Biosystems CoviPath COVID-19 RT-PCR Kit is approved for in vitro diagnostic use by the Indian Council for Medical Research (ICMR) and Drug Control General of India (DCGI)

Cramer spoke with Thermo Fisher Scientific CEO Marc Casper on Wednesday. Sign up and learn more about the CNBC Investing Club with Jim Cramer https://cnb.cx/3Ei22n4 » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. Connect with CNBC News Online Get the latest news: http://www.cnbc.com/ Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC https://www.cnbc.com/select/best-credit-cards/ #CNBC #CNBCTV

Jim Cramer chats with Thermo Fisher Scientific CEO Marc Casper about the rise of individualized medicine and where he sees the biotech industry is headed. » Subscribe to CNBC: http://cnb.cx/SubscribeCNBC » Watch more Mad Money here: http://bit.ly/WatchMadMoney » Read more about Thermo Fisher Scientific here: https://cnb.cx/2HGCQgu "Mad Money" takes viewers inside the mind of one of Wall Street's most respected and successful money managers. Jim Cramer is your personal guide through the confusing jungle of Wall Street investing, navigating through both opportunities and pitfalls with one goal in mind -- to try to help you make money. About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more. Get More Mad Money! Read the latest news: http://madmoney.cnbc.com Watch full episodes: http://bit.ly/MadMoneyEpisodes Follow Mad Money on Twitter: http://bit.ly/MadMoneyTwitter Like Mad Money on Facebook: http://bit.ly/LikeMadMoney Follow Cramer on Twitter: http://bit.ly/FollowCramer Connect with CNBC News Online! Visit CNBC.com: http://www.cnbc.com/ Find CNBC News on Facebook: http://cnb.cx/LikeCNBC Follow CNBC News on Twitter: http://cnb.cx/FollowCNBC Follow CNBC News on Google+: http://cnb.cx/PlusCNBC Follow CNBC News on Instagram: http://cnb.cx/InstagramCNBC Thermo Fisher Scientific CEO: Expanding in Emerging Markets | Mad Money | CNBC

Amit Chopra, CMD and VP/GM, India and South Asia, Thermo Fisher Scientific, Mumbai reveals how CoviPath is different from other kits available in market.

In an exclusive chat with Nano TV, the Asia Pacific head of Thermo Fisher Scientific draws plans for Indian markets and sees great potential for its product offerings in India. Watch for this exclusive industry talk on Nano TV. Watch this series only on Nano TV The Science Channel. facebook: https://www.facebook.com/nanodigest2009/ Linkedin : https://www.linkedin.com/in/nano-digest-254795185/

Title: How do you turn compliance into an opportunity? RoHs & REACH environmental regulations International Summit on Industrial Engineering December 08-10, San Francisco, USA OMICS International: http://conferenceseries.com/ OMICS open access Journals: http://omicsonline.org Global Medical Conferences: http://conferenceseries.com Global Pharmaceutical Conferences: http://pharmaceuticalconferences.com Global Cancer Conferences: http://cancersummit.org Global Diabetes Conferences: http://diabetesexpo.com Global Dental Conferences: http://dentalcongress.com Global Nursing Conferences: http://nursingconference.com Abstract Due to end of life concerns with electronics and the impact to human health and the environment, new product environmental regulations are rapidly becoming a challenge for electronics manufacturers. Based on the European RoHS and REACH requirements, it is imperative that manufacturers successfully comply with product environmental regulations in a timely manner. However, the real value is not just to comply, but to fully integrate these requirements into business processes and take advantage of new opportunities. Strategies for successful compliance will be discussed to turn compliance into an opportunity. The RoHS regulations target the removal of the six banned substances. RoHS was originally released in the European Union, but similar requirements have expanded globally. Throughout the supply chain, the substances shall be removed such that end products can be compliant.The REACH SVHC requirements target over 150 substances. New obligations have been set up to identify, communicate and phase out these substances. Based on detailed research of these restricted substances, these substances can be readily found in the supply chain. Communication is required throughout the electronics industry to identify usage and phase out restricted substances. This presentation will look at the complete product life cycle but will focus on the impacts of restricted substances. Opportunities to integrate the requirements into business processes will be covered along with optimizing systems. Biography Ken Kapur is leading the Global Compliance Engineering Group at Thermo Fisher Scientific LSG Division as an Associate Director; he is currently responsible for Product certification of Instruments at Thermo Fisher. He has an extensive background with over 25 years in Product Compliance. He has an Electrical Engineering Degree from the University of the Pacific and started his work in the area of product safety. He has expanded his expertise to cover a wide range of compliance requirements from Product Safety to Environmental Compliance. He has been invited to speak at a number of forums on various regulatory compliance topics globally.

Do you know which technologies are at the forefront of biotherapeutic characterization? The Biopharma Summit events, being held worldwide by Thermo Fisher Scientific, present a valuable opportunity for scientists to get together, share insight, and face the challenges of biopharma characterization together. Example topics include complete glycan characterization workflows, advanced fragmentation strategies, and breakthroughs in data management. Why attend the Biopharma Summit? Charles Olea, Analytical Chemist & Chemical Biologist at Ajinomotoe Althea, says, “The more heads in the room the better. Someone is going to know something that you don’t know, or you might know something that they don’t know.” Find out what other attendees thought of previous BioPharma Summit events, and their key takeaways, in this beautiful video from San Diego. --------------------- Read more of our articles here: https://themedicinemaker.com/ Sign up for free digital & physical copies here: https://themedicinemaker.com/login/sign-up This film was created by Texere Video Production. To find out more visit our website. To discuss your own video needs contact our team at video@texerepublishing.com Subscribe to The Medicine Maker official YouTube channel here: https://bit.ly/3aXH6EP Press the bell button to receive notifications whenever we post a new video. Follow us and access our latest content: Twitter: https://bit.ly/3C3coWV Facebook: https://bit.ly/3vBcBye Linkedin: https://bit.ly/3vKTulr Instagram: https://bit.ly/3jlzOPK Website: https://bit.ly/30MUQR8 To follow what we are doing at Texere follow us: Twitter: https://bit.ly/3nfDZ0P Facebook: https://bit.ly/3AZ9fWI Linkedin: https://bit.ly/3b1ZHj6 Instagram: https://bit.ly/3E8BoMO Website: https://bit.ly/3B51GxG

Thermo Fisher Scientific's Brisbane, Australia site is 2014 winner of the ISPE Facility of the Year award and 2015 winner of the Frost and Sullivan APAC CMO of the year award. The site provides scale up and manufacturing services of recombinant proteins and monoclonal antibodies. ---------------- Read more of our articles here: https://themedicinemaker.com/ Sign up for free digital & physical copies here: https://themedicinemaker.com/login/sign-up This film was created by Texere Video Production. To find out more visit our website. To discuss your own video needs contact our team at video@texerepublishing.com Subscribe to The Medicine Maker official YouTube channel here: https://bit.ly/3aXH6EP Press the bell button to receive notifications whenever we post a new video. Follow us and access our latest content: Twitter: https://bit.ly/3C3coWV Facebook: https://bit.ly/3vBcBye Linkedin: https://bit.ly/3vKTulr Instagram: https://bit.ly/3jlzOPK Website: https://bit.ly/30MUQR8 To follow what we are doing at Texere follow us: Twitter: https://bit.ly/3nfDZ0P Facebook: https://bit.ly/3AZ9fWI Linkedin: https://bit.ly/3b1ZHj6 Instagram: https://bit.ly/3E8BoMO Website: https://bit.ly/3B51GxG

Chris Langsdorf: Studying the immune response to viral infection with flow cytometry

Volunteers from Thermo Fisher Scientific promote STEM for kids at the 2018 Tech Challenge at the San Jose Tech Museum

The Thermo Scientific™ 2D-Barcode tubes offer a fast workflow with high sample integrity for optimal usage in biobanking processes. No matter if you need a simple system for your small lab or a complex high-tech solution for laboratory automization processes, we offer the right 2D-code tubes for you. Thermo Scientific™ tubes provide tracking, sample safety, high visibility and optimal performance when it comes to biobanking and cryo storage.

Talk: Applied Data science in Electron microscopy Yolanda van Dinther, Director Software Development, Electron Microscopy division, Thermo Fisher Scientific & Duygu Büyükaydin, Data Science Lead Engineer​, Thermo Fisher Scientific​ Bio Yolanda van Dinther is Director Software Development in the Electron Microscopy division of Thermo Fisher Scientific, leading Digital Transformation with a focus on unlocking and using the power of big and large data through AI technology. Also, she leads the local chapter in Eindhoven of the international women’s network in Thermo Fisher Scientific, guiding and advancing female talent in the company. Before joining Thermo Fisher Scientific 4 years ago, Yolanda worked in various innovation leadership roles, ranging from software to system development across a variety of high-tech companies in the healthcare, semiconductors, consumer, automotive, life sciences and printing industries. Yolanda holds a MSc degree in Computer Science from the University of Technology in Eindhoven and a Post Bachelor’s degree in Counseling Psychology. Abstract Thermo Fisher Scientific is the world leader in serving science. Through our Electron microscopy solutions our customers can combine high-resolution imaging with physical, elemental and chemical analysis to go from questions to usable information. In this talk we will demonstrate examples of data science applied to our imaging and system data. Bio Duygu Büyükaydin received her MSc in Signal Processing in 2006 from the Electrical&Electronics Engineering department of Middle East Technical University, Turkey. Duygu worked in several projects in defense domain and gained experience in signal processing and software development. She worked as a Data Scientist in Philips Healthcare. Currently she is Lead Engineer in Thermo Fisher Scientific. She is responsible for data science track of digital innovation. ​ Abstract Thermo Fisher Scientific is the world leader in serving science. Through our Electron microscopy solutions our customers can combine high-resolution imaging with physical, elemental and chemical analysis to go from questions to usable information. In this talk we will demonstrate examples of data science applied to our imaging and system data. Pipple & partners WiDS Netherlands aims to inspire and educate students, professionals and academics (men and women) through relating countless fantastic stories about women excelling in data science. The partners with whom Pipple is organising WiDS are Eindhoven University of Technology TU/e, EAISI (Eindhoven Artificial Intelligence Systems Institute), Maastricht University, University of Amsterdam, Amsterdam Data Science, Leiden University and Utrecht University. Diversity and inclusion Ymke de Jong (Data & AI lead, Philips Global Data & AI CoE Clinical Data Scientist, Digital Innovator in Healthcare and speaker at WiDS 2022) explains: “Data science is one of the fastest growing fields in the tech sector. It is crucial that everyone is represented here and that women are offered equal opportunities. At Philips we believe that a diverse, inclusive and committed workforce is essential for a flourishing and innovative company, helping our customers and improving healthcare. We hold ourselves and our organisation responsible for progress in the field of diversity and inclusion, and the promotion of a cooperation based on a purposeful, energetic work culture.'' In addition to Ymke de Jong, eleven other speakers shared their knowledge and experience on Monday 16 May 2022. Women in Data Science Women in Data Science (WiDS) is an independent annual conference organised by Stanford University. Together with the aforementioned universities, Pipple organises WiDS Netherlands each year. More info: www.wids.nl

Recording of the virtual EXCITE/ThermoFisher workshop that took place April 8th 2022. In this video the Thermo Scientific Software team presented their 3D visualization and analysis solutions. Highlights: Micro-CT Pore Size Distribution Relative Permeability Simulation BSE-EDS correlative analysis Python and Xtra library free add-ons Deep Learning Avizo versus PerGeos Q&A

Procalcitonin: Novel Clinical Approaches to Aid in Patient Management of Bacterial and Viral Pneumonias in the Critically Ill